G Protein‐Coupled Receptor 17 (Gpr17) Enhances Leptin and Insulin Sensitivity in Lean and Obese Mouse Models
Obesity · 2026-06 · 34 (S1) · 77-87
DOI: 10.1002/oby.70202 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Obesity, online erschienen am 13.05.2026. Verfasst von Xun Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Insulin Resistance, Leptin, Receptors, G-Protein-Coupled, Obesity. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health (NIH).
Abstract (Originalsprache)
Objective
Obesity, a major driver for diabetes development, is characterized by insulin and leptin resistance. We previously showed that loss of G protein‐coupled receptor 17 (Gpr17) in specific hypothalamic neurons and the intestine led to better energy balance and glucose metabolism. Our goal is to test whether general loss of Gpr17 enhances insulin and leptin sensitivity.
Methods
We generated germline Gpr17 knockout mice on both lean ( Gpr17 −/− ) and obese ( Gpr17 −/− ; ob/ob ) backgrounds and characterized their metabolic profile.
Results
Gpr17 −/− mice exhibited increased energy expenditure and oxygen consumption. Euglycemic‐hyperinsulinemic clamp studies showed enhanced insulin sensitivity in Gpr17 −/− mice with increased glycogen synthesis and decreased glycolysis. Gpr17 −/− ob/ob mice had increased insulin sensitivity with lower baseline serum insulin and higher response to exogenous leptin treatment with more reduction in feeding and increased pStat3 activation in hypothalamic nuclei.
Conclusions
These findings highlight the inhibitory effect of Gpr17 in leptin and insulin sensitivity, suggesting its potential as a therapeutic target for obesity treatment. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Indiana Biosciences Research Institute, Indianapolis, Indiana, USA.
- Division of Endocrinology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Yale Diabetes Research Center, New Haven, Connecticut, USA.
Förderung
- National Institutes of Health (NIH)
Zitieren
APA
Sun, X., Mahler, C., Stull, N. D., Nasiri, A., Zhou, B., Samuel, V., Shulman, G., Flak, J. N., & Ren, H. (2026). G Protein‐Coupled Receptor 17 (Gpr17) Enhances Leptin and Insulin Sensitivity in Lean and Obese Mouse Models. Obesity, 34(S1), 77-87. https://doi.org/10.1002/oby.70202
Vancouver
Sun X, Mahler C, Stull ND, Nasiri A, Zhou B, Samuel V, et al. G Protein‐Coupled Receptor 17 (Gpr17) Enhances Leptin and Insulin Sensitivity in Lean and Obese Mouse Models. Obesity. 2026;34(S1):77-87. doi:10.1002/oby.70202
BibTeX
@article{Sun2026,
author = {Sun, Xun and Mahler, Connor and Stull, Natalie D and Nasiri, Ali and Zhou, Baohua and Samuel, Varman and Shulman, Gerald and Flak, Jonathan N and Ren, Hongxia},
title = {G Protein‐Coupled Receptor 17 (Gpr17) Enhances Leptin and Insulin Sensitivity in Lean and Obese Mouse Models},
journal = {Obesity},
year = {2026},
volume = {34},
number = {S1},
pages = {77--87},
doi = {10.1002/oby.70202}
}
EUVIMED